Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Porphyria

1-methyl-3-isobutylxanthine has been researched along with Porphyria in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Varone, CL1
Canepa, ET1
Llambias, EB1
Grinstein, M1
Marks, GS1
Stephens, JK1
Fischer, PW1
Morgan, RO1

Reviews

1 review available for 1-methyl-3-isobutylxanthine and Porphyria

ArticleYear
Hormonal effects on the regulation of hepatic heme biosynthesis.
    Molecular and cellular biochemistry, 1979, May-21, Volume: 25, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 5-Aminolevulinate Synthetase; Allylisopropylacetamide; Androstanes; Ani

1979

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Porphyria

ArticleYear
Glucose inhibits phenobarbital-induced delta-aminolevulinate synthase expression in normal but not in diabetic rat hepatocytes.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 1996, Volume: 74, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 5-Aminolevulinate Synthetase; Aden

1996